Precision oncology: as much expectations as limitations

It is encouraging to witness the recent price reduction and expanded access to next generation sequencing platforms, the increasing number of investments and publications on new targets and respective targeted drugs, as well as the worldwide excitement with anti-cancer personalised therapies. This e...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasconcellos, Vitor Fiorin, Colli, Leandro Machado, Awada, Ahmad, de Castro Junior, Gilberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345072/
https://www.ncbi.nlm.nih.gov/pubmed/30679954
http://dx.doi.org/10.3332/ecancer.2018.ed86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345072/
https://www.ncbi.nlm.nih.gov/pubmed/30679954
http://dx.doi.org/10.3332/ecancer.2018.ed86

Ejemplares similares